PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

AI co-pilot boosts noninvasive brain-computer interface by interpreting user intent

Advancement shows promise for technology to assist immobilized individuals

2025-09-01
(Press-News.org) UCLA engineers have developed a wearable, noninvasive brain-computer interface system that utilizes artificial intelligence as a co-pilot to help infer user intent and complete tasks by moving a robotic arm or a computer cursor.

Published in Nature Machine Intelligence, the study shows that the interface demonstrates a new level of performance in noninvasive brain-computer interface, or BCI, systems. This could lead to a range of technologies to help people with limited physical capabilities, such as those with paralysis or neurological conditions, handle and move objects more easily and precisely.

The team developed custom algorithms to decode electroencephalography, or EEG — a method of recording the brain’s electrical activity — and extract signals that reflect movement intentions. They paired the decoded signals with a camera-based artificial intelligence platform that interprets user direction and intent in real time. The system allows individuals to complete tasks significantly faster than without AI assistance.

“By using artificial intelligence to complement brain-computer interface systems, we’re aiming for much less risky and invasive avenues,” said study leader Jonathan Kao, an associate professor of electrical and computer engineering at the UCLA Samueli School of Engineering. “Ultimately, we want to develop AI-BCI systems that offer shared autonomy, allowing people with movement disorders, such as paralysis or ALS, to regain some independence for everyday tasks.”

State-of-the-art, surgically implanted BCI devices can translate brain signals into commands, but the benefits they currently offer are outweighed by the risks and costs associated with neurosurgery to implant them. More than two decades after they were first demonstrated, such devices are still limited to small pilot clinical trials. Meanwhile, wearable and other external BCIs have demonstrated a lower level of performance in detecting brain signals reliably. 

To address these limitations, the researchers tested their new noninvasive AI-assisted BCI with four participants — three without motor impairments and a fourth who was paralyzed from the waist down. Participants wore a head cap to record EEG, and the researchers used custom decoder algorithms to translate these brain signals into movements of a computer cursor and robotic arm. Simultaneously, an AI system with a built-in camera observed the decoded movements and helped participants complete two tasks.

In the first task, they were instructed to move a cursor on a computer screen to hit eight targets, holding the cursor in place at each for at least half a second. In the second challenge, participants were asked to activate a robotic arm to move four blocks on a table from their original spots to designated positions. 

All participants completed both tasks significantly faster with AI assistance. Notably, the paralyzed participant completed the robotic arm task in about six-and-a-half minutes with AI assistance, whereas without it, he was unable to complete the task.

The BCI deciphered electrical brain signals that encoded the participants’ intended actions. Using a computer vision system, the custom-built AI inferred the users’ intent — not their eye movements — to guide the cursor and position the blocks.

“Next steps for AI-BCI systems could include the development of more advanced co-pilots that move robotic arms with more speed and precision, and offer a deft touch that adapts to the object the user wants to grasp,” said co-lead author Johannes Lee, a UCLA electrical and computer engineering doctoral candidate advised by Kao. “And adding in larger-scale training data could also help the AI collaborate on more complex tasks, as well as improve EEG decoding itself.”

The paper’s authors are all members of Kao’s Neural Engineering and Computation Lab, including Sangjoon Lee, Abhishek Mishra, Xu Yan, Brandon McMahan, Brent Gaisford, Charles Kobashigawa, Mike Qu and Chang Xie. A member of the UCLA Brain Research Institute, Kao also holds faculty appointments in the Computer Science Department and the Interdepartmental Ph.D. Program in Neuroscience.

The research was funded by the National Institutes of Health and the Science Hub for Humanity and Artificial Intelligence, which is a collaboration between UCLA and Amazon. The UCLA Technology Development Group has applied for a patent related to the AI-BCI technology. 
 

END


ELSE PRESS RELEASES FROM THIS DATE:

Black adults face heart failure nearly 14 years earlier than white patients

2025-09-01
Black adults first hospitalized for heart failure in the U.S. at age 60.1, vs. 73.6 for white adults Hispanic patients first hospitalized at 65.4; Asian American patients at 70.6 CHICAGO --- Black adults in the U.S. are first hospitalized for heart failure nearly 14 years earlier than white adults, reports a Northwestern Medicine study that analyzed data from more than 42,000 patients across hundreds of hospitals nationwide. The study also found that Hispanic patients were hospitalized about eight years earlier than white patients, and Asian patients about three years earlier. On average, white patients were first hospitalized ...

Study detects multidrug-resistant KPC-producing bacteria in Chilean wastewater for the first time

2025-09-01
A team of Chilean researchers has identified, for the first time in the country, the presence of KPC-type carbapenemase-producing bacteria in wastewater samples from the Greater Concepción Metropolitan Area. The finding, published in the journal Biological Research, raises concerns about the environmental circulation of microorganisms with high levels of resistance to critical clinically used antibiotics and reinforces the need for surveillance within the framework of "One Health." The research, which was part of Franco Ilabaca's Master's thesis in Microbiology, was led by Dr. ...

New artificial intelligence model accurately identifies which atrial fibrillation patients need blood thinners to prevent stroke

2025-09-01
Conference: “Late Breaking Science” presentation at the European Society of Cardiology - AI driven cardiovascular biomarkers and clinical decisions Title: Graph Neural Network Automation of Anticoagulation Decision-Making Date: Embargo lifts Monday, September 1, 4:00 pm EDT Bottom Line: Mount Sinai researchers developed an AI model to make individualized treatment recommendations for atrial fibrillation (AF) patients—helping clinicians accurately decide whether or not to treat them with anticoagulants (blood thinner medications) to prevent stroke, which is currently the standard treatment course in this patient population. This model presents a completely ...

Safety of factor XI inhibition with abelacimab in atrial fibrillation by kidney function

2025-09-01
About The Study: In this secondary analysis of the AZALEA-TIMI 71 randomized clinical trial, abelacimab consistently reduced the risk of bleeding relative to rivaroxaban irrespective of kidney function. These findings suggest that abelacimab may offer a particularly favorable safety profile among those with chronic kidney disease; however, larger studies are necessary to characterize the efficacy of abelacimab for stroke prevention in atrial fibrillation. Corresponding Author: To contact the corresponding author, Siddharth M. Patel, MD, MPH, email spatel@bwh.harvard.edu.  To access the embargoed study: Visit our For ...

Combination of mini-camera and AI predicts recurrent heart attack

2025-09-01
Measurements with a miniature camera inside the coronary arteries can accurately predict whether someone will suffer a recurrent heart attack. Until now, interpreting these images was so complex that only specialized laboratories could perform it. A new study from Radboud university medical center shows that AI can reliably take over this analysis and rapidly assess arteries for weak spots. A heart attack occurs when a coronary artery, which supplies the heart with blood, is blocked by a blood clot. This can occur when atherosclerosis causes artery narrowing, resulting in the heart receiving too little oxygen. Treatment typically ...

Study Reveals Details of Overactive Immune System in Patients with Chronic Fatigue Syndrome (ME/CFS)

2025-09-01
Patients with chronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS) have heightened innate immune responses to bacteria, viruses and fungi. While these responses are essential to fight infection, they can cause damage when unchecked. Led by researchers at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health with a multicenter team of leading ME/CFS researchers, the new study reveals molecular-level details into the syndrome’s lasting effects on inflammation and immune response that could inform the development of targeted therapeutic interventions to ...

UTSA and UT Health San Antonio complete merger to become The University of Texas at San Antonio

2025-09-01
SAN ANTONIO, Sept. 1, 2025 – UTSA and The University of Texas Health Science Center at San Antonio (UT Health San Antonio) today merged to form The University of Texas at San Antonio (UT San Antonio), a premier global university that is deeply committed to making lives better for the communities it serves. As a merged institution, UT San Antonio now ranks as the third-largest public research university in Texas according to annual research expenditures, behind only Texas A&M University and the University of Texas at Austin. UT San Antonio’s comprehensive enterprise now includes approximately 40,000 students, 17,000 employees and more than $486 million in annual ...

Helicobacter pylori screening after acute myocardial infarction

2025-09-01
About The Study: Among unselected patients with acute myocardial infarction, routine H pylori screening did not significantly reduce the risk of upper gastrointestinal bleeding. Corresponding Author: To contact the corresponding author, Robin Hofmann, MD, PhD, email robin.hofmann@ki.se. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. Embed this link to provide your readers ...

Solar Orbiter traces superfast electrons back to Sun

2025-09-01
The European Space Agency-led Solar Orbiter mission has split the flood of energetic particles flung out into space from the Sun into two groups, tracing each back to a different kind of outburst from our star. The Sun is the most energetic particle accelerator in the Solar System. It whips up electrons to nearly the speed of light and flings them out into space, flooding the Solar System with so-called ‘Solar Energetic Electrons’ (SEEs). Researchers have now used Solar Orbiter to pinpoint the source of these energetic electrons and trace what we see out in space back to what’s actually ...

GaN-based electron beam technology from Nagoya University startup poised to overcome critical semiconductor manufacturing challenges at KIOXIA

2025-09-01
NAGOYA, Japan — In late September 2025, KIOXIA Iwate Corporation (Koichiro Shibayama CEO) will begin evaluating a GaN-based e-beam technology developed through joint research between Photo electron Soul Inc. (PeS; Takayuki Suzuki CEO), a Nagoya University startup, and the Amano–Honda Laboratory at Nagoya University. PeS has developed a next-generation electron gun specialized for GaN (gallium nitride) photocathodes and has demonstrated its effectiveness for semiconductor inspection and metrology (I&M), enabling electron microscopy of nanoscale transistors and high-aspect-ratio structures. These ...

LAST 30 PRESS RELEASES:

Depression may make learning to avoid unpleasant events harder

Study sheds light on how pediatric brain tumors grow

Rare seasonal brain shrinkage in shrews is driven by water loss, not cell death

AI co-pilot boosts noninvasive brain-computer interface by interpreting user intent

Black adults face heart failure nearly 14 years earlier than white patients

Study detects multidrug-resistant KPC-producing bacteria in Chilean wastewater for the first time

New artificial intelligence model accurately identifies which atrial fibrillation patients need blood thinners to prevent stroke

Safety of factor XI inhibition with abelacimab in atrial fibrillation by kidney function

Combination of mini-camera and AI predicts recurrent heart attack

Study Reveals Details of Overactive Immune System in Patients with Chronic Fatigue Syndrome (ME/CFS)

UTSA and UT Health San Antonio complete merger to become The University of Texas at San Antonio

Helicobacter pylori screening after acute myocardial infarction

Solar Orbiter traces superfast electrons back to Sun

GaN-based electron beam technology from Nagoya University startup poised to overcome critical semiconductor manufacturing challenges at KIOXIA

Circle versus rectangle: Finding ‘Earth 2.0’ may be easier using a new telescope shape

Metformin changes blood metal levels in humans

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

[Press-News.org] AI co-pilot boosts noninvasive brain-computer interface by interpreting user intent
Advancement shows promise for technology to assist immobilized individuals